Fahim Abbasi

Glenn M. Chertow is a distinguished nephrologist based in Palo Alto, California, affiliated with Stanford University School of Medicine. He holds multiple academic appointments and has received numerous accolades for his contributions to the field of medicine, particularly in nephrology and epidemiology. With a robust educational background from prestigious institutions such as Harvard Medical School and the University of Pennsylvania, Dr. Chertow is recognized for his research and clinical expertise. His work has garnered him various honors, including designations as a top doctor and membership in the American Society of Clinical Investigation. Generated from the website

Dr. Kristina Kudelko is a highly qualified pulmonary hypertension specialist and critical care pulmonologist based in Palo Alto, CA. She serves as a Clinical Professor of Medicine and is affiliated with the Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford University Medical Center. With extensive training and board certifications in internal medicine, pulmonary disease, and critical care medicine, Dr. Kudelko has a notable background that includes fellowships at prestigious institutions and numerous awards for her research and teaching contributions. Her commitment to advancing the field is reflected in her administrative roles and active participation in clinical education and faculty wellness initiatives. Generated from the website

Dr. Francois Haddad, MD is a Clinical Professor of Medicine that specializes in the field of cardio-vascular imaging, pulmonary hypertension, advanced heart failure and transplantation. Dr. Haddad has over 18 years of practice in the field of cardiology. He directs Stanford Cardiovascular Institute Biomarker and Phenotypic Core Laboratory dedicated to translational studies in cardiovascular medicine. The laboratory focuses on (1) identifying early biomarkers of heart failure and aging, (2) bioengineering approaches to cardiovascular disease modeling and (3) novel informatic approach for the detection and risk stratification of disease.